40
Participants
Start Date
September 1, 2025
Primary Completion Date
December 1, 2027
Study Completion Date
September 1, 2029
Biomarker Targeted Stimulation (BTS)
Using continuous stimulation to target multiple network nodes, Biomarker Targeted Stimulation (BTS) is intended to suppress abnormal interictal activity, as determined by biomarkers including interictal epileptiform discharges (IED) and high frequency oscillations (HFO), with the intention to reduce brain hyperexcitability, thereby limiting seizure occurrence.
Lead Sponsor
Cadence Neuroscience
INDUSTRY